CCL2 and experimental autoimmune encephalomyelitis: Numerous human and animal studies have highlighted the chemokine CCL2 (formerly known as MCP-1[1]) as a critical mediator of the neuroinflammatory disease multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE)[2-4].